| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 10/08/2002 | US6462185 Floral organ-specific gene and its promoter sequence |
| 10/08/2002 | US6462177 Mammalian blood loss-induced gene, kd312 |
| 10/08/2002 | US6462175 Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use |
| 10/08/2002 | US6462172 Purification of tissue plasminogen activator (TPA) |
| 10/08/2002 | US6462027 Genetic vaccination of fish and crustaceans against parasites, bacteria and viruses; use in aquaculture industry, for example |
| 10/08/2002 | US6461871 Comprising sequence recognition and reporting group portions; determining background signals |
| 10/08/2002 | US6461867 Synthetic antigen presenting matrix |
| 10/08/2002 | US6461865 Calreticulin-deficient cells |
| 10/08/2002 | US6461864 Inserting dna construct into pluripotent cell comprising heterologous dna; genetic engineering |
| 10/08/2002 | US6461863 Modifying insect cell gylcosylation pathways with baculovirus expression vectors |
| 10/08/2002 | US6461856 Genes encoding picric acid degradation |
| 10/08/2002 | US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis |
| 10/08/2002 | US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity |
| 10/08/2002 | US6461852 Dihydrodipicolinate synthase from Bacillus methanolicus |
| 10/08/2002 | US6461851 High expression modules containing two or more tandem copies of a methioninase encoding sequence |
| 10/08/2002 | US6461850 Peptides selected by homology and/or structural relatedness to known protease proteins of the choriolytic hatching protease subfamily and expression pattern observed |
| 10/08/2002 | US6461848 Degrades heparin sulfate preventing deposits of beta-amyloid senile plaques |
| 10/08/2002 | US6461846 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 10/08/2002 | US6461843 Isolated nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 10/08/2002 | US6461842 Expressing gene which encodes decaprenyl diphosphate synthase; molecular hybridization |
| 10/08/2002 | US6461841 L-amino acid oxidase from Rhodococcus species |
| 10/08/2002 | US6461838 Polyketides |
| 10/08/2002 | US6461837 Methods for producing a polypeptide using a consensus translational initiator sequence |
| 10/08/2002 | US6461836 Molecular cloning of a 7TM receptor (AxOR34) and screening methods thereof |
| 10/08/2002 | US6461826 Essential fungal genes and their use |
| 10/08/2002 | US6461824 Production of chimeric antibodies with specificity to human tumor antigens |
| 10/08/2002 | US6461823 Death domain containing receptor-4 antibodies |
| 10/08/2002 | US6461822 Therapeutic targets for agents that suppress the release of inflammatory mediators such as interleukin il-1 and il-1 beta |
| 10/08/2002 | US6461818 Method for chromosomal rearrangement by consecutive gene targeting of two recombination substrates to the deletion endpoints |
| 10/08/2002 | US6461817 Non-competitive co-amplification methods |
| 10/08/2002 | US6461814 Method of identifying gene transcription patterns |
| 10/08/2002 | US6461811 Gamma-herpes virus DNA and methods of use |
| 10/08/2002 | US6461807 Methods for drug target screening |
| 10/08/2002 | US6461734 Substrate for supporting high-density biological and chemical arrays comprising boroaluminosilicate glass material having limited sodium oxide content, specified top surface roughness, and uniform functionalized coating of polar silane on portion |
| 10/08/2002 | US6461617 Recombinant toxin fragments |
| 10/08/2002 | US6461616 EIAV p26 deletion vaccine and diagnostic |
| 10/08/2002 | US6461614 Fibronectin binding proteins |
| 10/08/2002 | US6461609 Recombinant α-galactosidase a therapy for Fabry disease |
| 10/08/2002 | US6461608 E. coli |
| 10/08/2002 | US6461607 Probiotic, lactic acid-producing bacteria and uses thereof |
| 10/08/2002 | US6461606 Materials and methods for gene therapy |
| 10/08/2002 | US6461571 Method for prolonged storage of DNA molecules and packaging implementing said method |
| 10/08/2002 | CA2231046C Human protein kinases hyak3 |
| 10/08/2002 | CA2126680C Novel megakaryocyte potentiator |
| 10/08/2002 | CA2047119C Vitro processing of fusion proteins |
| 10/06/2002 | CA2378565A1 Crystal structure |
| 10/03/2002 | WO2004031223A1 A novel modulator of non-genonic activity of nuclear receptors (mnar) and uses thereof |
| 10/03/2002 | WO2003085082A2 Nucleic acid reactions using labels with different redox potentials |
| 10/03/2002 | WO2002077895A2 Method for epigenetic feature selection |
| 10/03/2002 | WO2002077648A2 Pathogenic and commensal vaccine antigens |
| 10/03/2002 | WO2002077642A1 Mthod of screening drug for preventing/treating proliferative glomerular nephritis |
| 10/03/2002 | WO2002077637A1 Sex-specific selection of sperm from transgenic animals |
| 10/03/2002 | WO2002077620A1 Device for referencing fluorescence signals |
| 10/03/2002 | WO2002077293A2 Detection of fungal pathogens using the polymerase chain reaction |
| 10/03/2002 | WO2002077289A1 Methods for the synthesis of polynucleotides and combinatorial libraries of polynucleotides |
| 10/03/2002 | WO2002077287A1 Apparatus and method for sequencing a nucleic acid |
| 10/03/2002 | WO2002077286A1 Mutation detection using muts and reca |
| 10/03/2002 | WO2002077279A1 Method of evaluating useful cattle |
| 10/03/2002 | WO2002077278A1 Universal primers for wildlife identification |
| 10/03/2002 | WO2002077276A2 Novel signalling polypeptide |
| 10/03/2002 | WO2002077275A2 Diagnostic method for determining abnormality of cloned embryos |
| 10/03/2002 | WO2002077274A2 Methods for purifying and detecting double stranded dna target sequences by triple helix interaction |
| 10/03/2002 | WO2002077272A2 Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders |
| 10/03/2002 | WO2002077267A2 Nucleic acid molecules encoding a transmembran serine protease 9, the encoded polypeptides and methods based thereon |
| 10/03/2002 | WO2002077266A2 Novel fibroblast growth factor and nucleic acids encoding same |
| 10/03/2002 | WO2002077264A2 Arrayed transfection method and uses related thereto |
| 10/03/2002 | WO2002077263A2 Nucleic acid molecules encoding serine protease cvsp14, the encoded polypeptides and methods based thereon |
| 10/03/2002 | WO2002077261A2 Human potassium channel |
| 10/03/2002 | WO2002077258A1 Stereoselective reduction of substituted acetophenone |
| 10/03/2002 | WO2002077249A2 Type iii bacterial strains for use in medicine |
| 10/03/2002 | WO2002077248A1 Vegetative growth-specific promoter and genetically modified plants obtained thereby |
| 10/03/2002 | WO2002077247A1 Rice-origin high expression polypeptide chain elongation factor promoter and method of using the same |
| 10/03/2002 | WO2002077246A2 Site-targeted transformation using amplification vectors |
| 10/03/2002 | WO2002077244A1 Transformant producing pf1022 substance derivatives, process for producing the same and novel biosynthesis gene |
| 10/03/2002 | WO2002077243A1 Diagnosis of cancer or benign tumour using the aberrant expression product of the klk4 gene |
| 10/03/2002 | WO2002077242A2 Family 74 xyloglucanases |
| 10/03/2002 | WO2002077241A2 Isolated human metalloprotease proteins, nucleic acid molecules encoding human protease proteins, and uses thereof |
| 10/03/2002 | WO2002077240A1 Deoxymugineic acid synthase and gene thereof |
| 10/03/2002 | WO2002077239A1 Hcv-binding polypeptides |
| 10/03/2002 | WO2002077238A1 Gene encoding lectin protein originating in gorse, protein encoded by the gene and process for producing the same |
| 10/03/2002 | WO2002077237A2 Transporters and ion channels |
| 10/03/2002 | WO2002077236A2 Compositions and methods relating to lung specific genes and proteins |
| 10/03/2002 | WO2002077235A2 Intracellular signaling molecules |
| 10/03/2002 | WO2002077234A2 Compositions and methods relating to colon specific genes and proteins |
| 10/03/2002 | WO2002077233A2 38650, 28472, 5495, 65507, 81588 and 14354 METHODS AND COMPOSITIONS OF HUMAN PROTEINS AND USES THEREOF |
| 10/03/2002 | WO2002077232A2 Compositions and methods relating to breast specific genes and proteins |
| 10/03/2002 | WO2002077231A2 Nucleic acid-associated proteins |
| 10/03/2002 | WO2002077230A1 Nr10 splicing variants |
| 10/03/2002 | WO2002077229A2 Cofactors of the liver x receptor alpha and methods of use |
| 10/03/2002 | WO2002077228A1 Gene involved in v(d)j recombination and/or dna repair |
| 10/03/2002 | WO2002077227A2 Iterative optimization in the design of binding proteins |
| 10/03/2002 | WO2002077225A1 Method for isolating dna |
| 10/03/2002 | WO2002077223A1 Novel aminopeptidase and its gene |
| 10/03/2002 | WO2002077221A1 Packaging cell lines for the continuous production of alphavirus vectors |
| 10/03/2002 | WO2002077220A2 Nucleic acids encoding human est1 proteins |
| 10/03/2002 | WO2002077218A1 Coagulation factor vii derivatives |
| 10/03/2002 | WO2002077217A2 Human dual specificity protein phosphatase 7-like protein |
| 10/03/2002 | WO2002077216A2 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby |
| 10/03/2002 | WO2002077213A2 New elongase gene and production of δ9-polyunsaturated fatty acids |
| 10/03/2002 | WO2002077212A2 D-carbamoylase from arthrobacter crystallopoietes dsm 20117 |